asciminib,bosutinib
pfizer,novartis
['leusm', 'asciminib', 'cml', 'bosutinib']
ascembl shows the superiority of asciminib over bosutinib in improving survival among pts w/ cml. #asco22 #ascodailynews #hemonc #leusm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.